SYMBIOTEC climbs 14.6% while Nifty 50 adds 0.15%
Key Highlights
Symbiotec Pharmalab Ltd. share price rose 14.64% to ₹1,457.70 at 09:39 IST. The company reported a net profit of ₹14 crore for Q1 FY27.
- SYMBIOTEC rose 14.64% to ₹1,457.70 at 09:39 IST on 6 Nov 2026.
- so far was 2.90× its 20-session average.
- Q1 FY27 net profit: ₹14 crore.
Figures as of: 09:39 IST, Friday 6 November 2026
Symbiotec Pharmalab Ltd. (SYMBIOTEC) share price rose 14.64% to ₹1,457.70 at 09:39 IST on Friday 6 November 2026. The trading volume reached 2.90× the 20-session average. The company filed its Q1 FY27 results on Thursday 5 November 2026, and the stock traded at ₹1,457.70 on Friday.
SYMBIOTEC share price today
| Price (09:39 IST) | ₹1,457.70 |
| Change from the previous close (₹1,271.50) | +₹186.20 (+14.64%) |
| Day’s range | ₹1,320.00 – ₹1,464.20 |
| Volume so far | 19.9 lakh shares |
| 20-session average daily volume | 6.9 lakh shares (volume so far is 2.90× that) |
| Closing prices of the previous 4 sessions | ₹1,225.00 – ₹1,271.50 |
| 52-week range (adjusted prices) | ₹934.20 – ₹1,309.90 |
| Market value at this price | ₹9,367 crore |
The share price traded between ₹1,320.00 and ₹1,464.20 during the session. Trading volume reached 19.9 lakh shares, which is 2.90× the 20-session average daily volume. The current price of ₹1,457.70 is 56.0% above the 52-week low.
What has been announced
| When (IST) | Filing |
|---|---|
| Thu 5 Nov, 8:34 pm | Announcement under Regulation 30 (LODR)-Monitoring Agency Report |
| Thu 5 Nov, 8:23 pm | Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Thu 5 Nov, 8:20 pm | Announcement under Regulation 30 (LODR)-Investor Presentation |
| Thu 5 Nov, 7:59 pm | Results-Financials Results For Sep 30 2026 (Outcome Of Board Of Directors Of The Company In Its Meeting Held Today I.E. Thursday November 05 2026) |
| Thu 5 Nov, 7:47 pm | Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. Thursday November 05 2026 Have Inter Alia Considered And Approved The Unaudited & Financial Results For The Quarter And Half Year Ended September 30 2026 |
Q1 FY27 results at a glance
| ₹ crore | Q1 FY27 |
|---|---|
| from operations | 218 |
| 18 | |
| Net profit | 14 |
| Net profit as a share of revenue | 6.45% |
The company reported revenue from operations of ₹218 crore for the Q1 FY27 quarter. Profit before tax stood at ₹18 crore for the period. The net profit was ₹14 crore, representing 6.45% of the total revenue.
How SYMBIOTEC compares with its sector
| Change today | |
|---|---|
| SYMBIOTEC | +14.64% |
| +0.15% |
The Pharmaceuticals & Drugs stock gained 14.64% while the Nifty 50 index rose 0.15%. The company holds a market value of ₹9,367 crore at the current price of ₹1,457.70.
SYMBIOTEC share price: FAQs
What is the SYMBIOTEC share price today?
₹1,457.70 at 09:39 IST on Friday 6 November 2026, up ₹186.20 or 14.64% from the previous close of ₹1,271.50.
What were SYMBIOTEC’s Q1 FY27 results?
Consolidated revenue from operations of ₹218 crore and net profit of ₹14 crore, for the quarter ended 30 June 2026.
When did SYMBIOTEC announce the results?
The board meeting outcome was filed on Thu 5 Nov, 7:47 pm IST.
This article is for information only and is not investment advice. Prices are from the National Stock Exchange, filings from BSE announcements and results from the company’s reported figures. Calculations are by ThePip. Prices and figures move through the session; the time above says when these were read. Investments in securities are subject to market risks.